Samrat Pharmachem Ltd. benchmarking: Perfomance to industry peers

Financial

	Samrat Pharmachem	Vivo Bio Tech	Vineet Laboratories
Operational Metrics
Financials
5 yr Average ROE	18.86 %	7.43 %	-20.75 %
5yr average Equity Multiplier	1.83	2.24	4.27
5yr Average Asset Turnover Ratio	2.61	0.43	1.52
5yr Avg Net Profit Margin	3.87 %	8.3 %	-4.28 %
Price to Book	0.89	0.66	4.36
P/E	40.47	15.62	0.0
5yr Avg Cash Conversion Cycle	58.79 Days	90.56 Days	179.8 Days
Inventory Days	28.98 Days	72.05 Days	114.74 Days
Days Receivable	80.32 Days	90.11 Days	109.14 Days
Days Payable	46.76 Days	88.09 Days	115.29 Days
5yr Average Interest Coverage Ratio	16.47	2.13	1.29
5yr Avg ROCE	27.43 %	13.85 %	-1.66 %
5yr Avg Operating Profit Margin	5.58 %	39.67 %	-0.62 %
5 yr average Debt to Equity	0.21	1.08	1.24
5yr CAGR Net Profit	5.93 %	5.09 %	n/a
5yr Average Return on Assets	10.3 %	3.6 %	-2.52 %
Shareholdings
Promoter Holding	49.09 %	35.16 %	12.46 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.45 %	-7.0 %	-23.5 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Samrat Pharmachem	Vivo Bio Tech	Vineet Laboratories
Product Wise Break-Up	Product Wise Break-Up Contract Research Organization(CRO) 0 Others 100	Product Wise Break-Up CRO 100.0	Product Wise Break-Up Contract Research Organization(CRO) 0 Others 100